Table 1.
Overall | 1st Quartilea (Lowest) | 2nd Quartilea | 3rd Quartilea | 4th Quartilea (Highest) | p-value | |
---|---|---|---|---|---|---|
(n=35,283) | (n=4,576) | (n=7,883) | (n=10,900) | (n=11,924) | ||
Device confirmation of correct endotracheal tube placement | ||||||
Eligible patients | 16,572 (47.0) | 2,380 (52.0) | 3,996 (50.7) | 4,797 (44.0) | 5,399 (45.3) | 0.17 |
Received measure | 14,217 (85.8) | 1,684 (70.8) | 3,126 (78.2) | 4,317 (90.0) | 5,090 (94.3) | |
Percent pulseless cardiac events monitored or witnessed | ||||||
Eligible patients | 32,014 (90.7) | 4,057 (88.7) | 7,121 (90.3) | 10,009 (91.8) | 10,827 (90.8) | 0.36 |
Received measure | 30,093 (94.0) | 3,627 (89.4) | 6,574 (92.3) | 9,413 (94.0) | 10,479 (96.8) | |
Time to first chest compressions ≤1 min | ||||||
Eligible patients | 34,215 (97.0) | 4,359 (95.3) | 7,624 (96.7) | 10,471 (96.1) | 11,761 (98.6) | 0.18 |
Received measure | 32,607 (95.3) | 3,915 (89.8) | 7,105 (93.2) | 10,038 (95.9) | 11,549 (98.2) | |
Time to first shock ≤2 mins for VF/VT | ||||||
Eligible patients | 5,113 (14.5) | 684 (14.9) | 1,156 (14.7) | 1,563 (14.3) | 1,710 (14.3) | 0.08 |
Received measure | 3,051 (59.7) | 338 (49.4) | 649 (56.1) | 926 (59.2) | 1,138 (66.5) | |
Time to IV/IO epinephrine/vasopressin bolus administered to pulseless adults ≤5 mins | ||||||
Eligible patients | 22,003 (62.4) | 2,599 (56.8) | 4,675 (59.3) | 7,088 (65.0) | 7,641 (64.1) | 0.14 |
Received measure | 19,731 (89.7) | 2,148 (82.6) | 4,107 (87.9) | 6,353 (89.6) | 7,123 (93.2) |
Abbreviations: ET, endotracheal tube; IQR, interquartile range; IV/IO, intravenous/intraosseous; min, minutes; VF/VT, ventricular fibrillation/ventricular tachycardia
Quartiles are divided into equal hospital quartiles based on sequentially ordered composite quality performance scores.